Breast Health: Expert Assessment of Breast Symptoms

Breast symptoms — a new lump, unexplained pain, a change in appearance, or discharge — almost always cause anxiety, and that anxiety is entirely understandable. The breast is not just a body part; concern about it carries an enormous emotional weight. In my practice, I take every breast symptom seriously, however large or small it may seem to the patient presenting it. My specialist training in breast diseases, which I undertook at the Breast Diseases Centre at Saint-Louis Hospital in Paris — one of France's leading breast disease units — gives me both the clinical expertise and the diagnostic confidence to assess, investigate, and manage a wide range of breast conditions. The majority of symptoms, particularly in younger women, will have a benign explanation. But the appropriate path to that reassurance is a thorough clinical assessment, not delay or dismissal.

Services Offered

My breast health service encompasses a comprehensive range of assessments and management approaches:

• Clinical breast examination — thorough, systematic examination of both breasts, axillae (armpits), and supraclavicular regions, with documentation of any abnormalities
• Assessment of lumps and focal nodularity — clinical characterisation of breast masses: size, consistency, mobility, borders, tenderness, and skin changes
• Nipple discharge evaluation — differentiation of physiological, hormonal, and pathological discharge; galactorrhoea assessment including prolactin levels
• Breast pain (mastalgia) — detailed assessment to distinguish cyclic from non-cyclic mastalgia; hormonal and non-hormonal management strategies
• Skin and nipple changes — assessment of skin tethering, dimpling, redness, peau d'orange appearance, nipple inversion, or eczematous changes
• Post-surgical review — follow-up for women who have undergone breast procedures, including scar assessment and monitoring
• Referral for mammography, breast ultrasound, or biopsy — coordination with specialist radiology and surgical breast units when further investigation is required
• Hormonal risk counselling — discussion of HRT, the combined contraceptive pill, and breast cancer risk; personalised risk-benefit assessment
• Genetic risk assessment and referral — for women with a significant family history of breast or ovarian cancer, appropriate referral to clinical genetics services for BRCA testing and risk management

Breast Pain: Cyclic Versus Non-Cyclic Mastalgia

Breast pain (mastalgia) is one of the most common reasons women attend breast clinics, and the vast majority of cases are entirely benign. The first step is to categorise the pain accurately, because the causes and management differ considerably.

Cyclic mastalgia is the most common type. It is hormonally driven, typically bilateral, and characteristically worsens in the second half of the menstrual cycle before easing with menstruation. It often presents as a generalised ache or heaviness, most prominent in the outer upper quadrants of the breast. It is closely linked to the hormonal fluctuations of the normal cycle — and in some women, to the hormonal changes of perimenopause. Reassurance and confirmation of its benign nature is often the most important intervention. Where symptoms are significant, options include: evening primrose oil (GLA content — the evidence is modest but it is well tolerated), supportive bra fitting, dietary modifications, and in some cases hormonal adjustment (for example, reviewing a combined pill formulation, or considering progestogen supplementation in the luteal phase).

Non-cyclic mastalgia is more varied in its causes. It may be focal — pointing to a specific area of the breast that may warrant imaging — or it may be musculoskeletal in origin (costochondritis or intercostal muscle pain are common mimics of breast pain). Focal, persistent, non-cyclic pain, particularly in women over 35, warrants clinical assessment and usually breast imaging to exclude an underlying structural cause.

Nipple Discharge

Nipple discharge understandably causes alarm, but context is everything. Galactorrhoea — milky discharge from one or both breasts in a woman who is not breastfeeding — is almost always hormonal in origin. Raised prolactin levels (from a pituitary microadenoma, certain medications, or thyroid dysfunction) are the most common cause, and a simple blood test usually provides the answer. It is benign in the vast majority of cases and entirely treatable.

The type of discharge matters clinically. Clear or slightly cloudy bilateral discharge provoked only by squeezing is generally benign. Unilateral discharge, particularly if it is blood-stained, serous, or spontaneous (occurring without squeezing), requires prompt investigation, as it may indicate intraductal pathology such as a papilloma — or, less commonly, ductal carcinoma in situ. I take a careful history of the discharge character, laterality, and any associated symptoms, and arrange referral for appropriate imaging and specialist assessment where indicated.

Lumps and Focal Changes

The discovery of a breast lump is one of the most anxiety-provoking experiences a woman can have — and one of the most common reasons for attending my clinic. I want to offer clear reassurance while being clinically rigorous: the majority of breast lumps in women under 35 are entirely benign. Fibroadenomas — smooth, mobile, well-defined "breast mice" — are the most common cause of a new lump in young women and are a normal variant of breast tissue development. Simple cysts (fluid-filled sacs) are extremely common, particularly in women in their thirties and forties, and are almost invariably benign.

That said, all new or changing breast lumps require appropriate assessment, regardless of age. Clinical assessment alone is insufficient; a clinical finding must be correlated with imaging and, where necessary, histology. This is captured in the concept of triple assessment: the combination of clinical examination, breast imaging (ultrasound and/or mammography), and tissue sampling (fine needle aspiration or core biopsy). When triple assessment is concordant in showing benign features, the negative predictive value is extremely high. I coordinate this process on your behalf and help you understand what each step means.

Monitoring Hormonal Factors

Many women who come to me with breast concerns are already taking, or considering taking, hormonal treatments — HRT, the combined oral contraceptive pill, or progesterone supplementation — and want to understand how these affect their breast health and cancer risk.

HRT and breast density are closely related: oestrogen and progesterone can increase mammographic density, which can make imaging interpretation more challenging. Body-identical HRT using micronised progesterone carries a more favourable breast cancer risk profile than combined preparations using synthetic progestogens, and I discuss this nuance carefully with patients during HRT consultations.

The combined pill carries a small increase in relative breast cancer risk that returns to baseline after stopping. For most women, this risk is outweighed by the benefits of contraception and cycle regulation — but it is worth understanding, and I factor it into individual discussions.

For women with a strong family history of breast or ovarian cancer — particularly where BRCA1 or BRCA2 mutations are known or suspected — early specialist genetics referral is appropriate, and I can coordinate this directly. Risk-reducing strategies, enhanced surveillance programmes, and prophylactic options can all be discussed within that specialist framework.

When to Seek Urgent Assessment

While the majority of breast symptoms are benign, the following changes warrant prompt specialist review — ideally within two weeks:

• A new, hard, or irregularly shaped lump that does not move freely
• Skin tethering, dimpling, or puckering overlying a lump or area of thickening
• Nipple inversion that is new or progressive (particularly if unilateral)
• Blood-stained or clear unilateral nipple discharge that is spontaneous
• Swelling, redness, or warmth in the breast not explained by infection
• Enlarged lymph nodes in the armpit (axillary lymphadenopathy)
• Rapid or unexplained change in breast size or shape
• An eczema-like rash affecting the nipple or areola that does not resolve

If you are in any doubt, please do not wait. A swift assessment that results in reassurance is always time well spent.

What to Expect at Your Consultation

Your appointment begins with a thorough history: the nature of your symptom, when it began, how it has changed, your personal and family medical history, and your current medications including any hormonal treatments. I will then perform a clinical breast examination with your consent, in a private and comfortable environment.

Following the examination, I will explain my clinical findings clearly and discuss what, if any, further investigations are needed. If imaging is required — breast ultrasound for women under 40, mammography with or without ultrasound for women over 40 — I will arrange this promptly through appropriate specialist radiology partners and review the results with you. If a biopsy is recommended, I will explain the procedure, what it involves, and what the results will tell us. You will never be left managing findings alone.

Breast health is an integral part of women's health, and I am proud to offer the level of specialist assessment in this area that my training and experience allow. Whatever your concern, however small it may feel, I am here to listen, examine, and act appropriately. Your peace of mind matters — and sometimes so does timely action.